Literature DB >> 24879167

Lidocaine reduces endotracheal tube associated side effects when instilled over the glottis but not when used to inflate the cuff: A double blind, placebo-controlled, randomized trial.

Radhouane Bousselmi, Mohamed Anis Lebbi, Abderrahmen Bargaoui, Marien Ben Romdhane, Abdelhakim Messaoudi, Abdelkader Ben Gabsia, Mustapha Ferjani.   

Abstract

BACKGROUND: Tracheal intubation results in an alteration of the laryngeal mucosa which can lead to undesirable effects at emergence from anaesthesia. Local anesthetics, when administered topically, may represent an interesting alternative to reduce these side effects. AIM: In this trial, we aimed to evaluate the effect of lidocaine in preventing tracheal intubation related side effects at emergence from anaesthesia, when instilled onto the glottis before intubation or used to inflate the endotracheal tube cuff.
METHODS: Eighty patients scheduled to elective surgery of less than 120 minutes under general anaesthesia were enrolled in this prospective, randomized, controlled, double blind study. As they receive instillation of 2% lidocaine or saline onto the glottis before intubation, and as they have their endotracheal tube cuff filled with 2% lidocaine or saline, the patients were randomized in four groups. S-S (Saline instillation and saline in the cuff); S-Lido (saline instillation and lidocaine in the cuff); Lido-S (lidocaine instillation and saline in the cuff); Lido-Lido (lidocaine instillation and lidocaine in the cuff). The primary outcome was the incidence of coughing before extubation. The secondary outcomes were sore throat scores at H1 and H24 postoperatively and incidence of dysphagia, dysphonia and laryngeal dyspnea during the first 24 hours.
RESULTS: Coughing occurred in 80%, 70%, 30% and 20% of patients in S-S, S-Lido, Lido-S and Lido-Lido groups respectively. When compared to S-S group, the incidence of coughing was significantly reduced in Lido-S and Lido-Lido groups but not in S-Lido group (p1=0.003; p2=0.0003; p3=0.7 respectively). Sore throat scores at H1 and H24 were significantly lower in Lido-S and Lido-Lido groups (p1=0.00002 and p2=0.01). There was no significant difference between groups regarding the incidence of dysphagia, dysphonia and laryngeal dyspnea.
CONCLUSION: When instilled onto the glottis before intubation, lidocaine reduced both the incidence of coughing and the severity of postoperative sore throat in surgery of less than 120 minutes. Intracuff lidocaine was not effective to reduce neither coughing nor sore throat severity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24879167

Source DB:  PubMed          Journal:  Tunis Med        ISSN: 0041-4131


  5 in total

1.  The Efficacy of Lidocaine in Laryngospasm Prevention in Pediatric Surgery: a Network Meta-analysis.

Authors:  Xiaojing Qi; Zhoupeng Lai; Si Li; Xiaochen Liu; Zhongxing Wang; Wulin Tan
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379

Review 2.  Effect of Intracuff Lidocaine on Postoperative Sore Throat and the Emergence Phenomenon: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Fai Lam; Yu-Cih Lin; Hsiao-Chien Tsai; Ta-Liang Chen; Ka-Wai Tam; Chien-Yu Chen
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

3.  Effect of inhaled budesonide suspension, administered using a metered dose inhaler, on post-operative sore throat, hoarseness of voice and cough.

Authors:  Sunil Rajan; Pulak Tosh; Jerry Paul; Lakshmi Kumar
Journal:  Indian J Anaesth       Date:  2018-01

4.  Comparison of Effect of Airway Nebulization with Lignocaine 2% versus Ropivacaine 0.25% on Intubation and Extubation Response in Patients Undergoing Surgery under General Anesthesia: A Randomized Double-Blind Clinical Trial.

Authors:  Ramyavel Thangavelu; Ranjan R Ventakesh; Kandasamy Ravichandran
Journal:  Anesth Essays Res       Date:  2018 Apr-Jun

5.  Efficacy of intracuff lidocaine in reducing coughing on tube: a systematic review and meta-analysis.

Authors:  Fei Peng; Maohua Wang; Huihuang Yang; Xiaoli Yang; Menghong Long
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.